C
Chris Robertson
Researcher at University of Strathclyde
Publications - 441
Citations - 26994
Chris Robertson is an academic researcher from University of Strathclyde. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 72, co-authored 392 publications receiving 22264 citations. Previous affiliations of Chris Robertson include University of Glasgow & Health Protection Scotland.
Papers
More filters
Journal ArticleDOI
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.
Umberto Veronesi,Giovanni Paganelli,Giuseppe Viale,Alberto Luini,Stefano Zurrida,Viviana Galimberti,Mattia Intra,Paolo Veronesi,Chris Robertson,Patrick Maisonneuve,Giuseppe Renne,Concetta De Cicco,Francesca De Lucia,R. Gennari +13 more
TL;DR: Sentinel-node biopsy is a safe and accurate method of screening the axillary nodes for metastasis in women with a small breast cancer.
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer
Umberto Veronesi,Giovanni Paganelli,Giuseppe Viale,Alberto Luini,S. Zurrida,Viviana Galimberti,Mattia Intra,Paolo Veronesi,Chris Robertson,Patrick Maisonneuve,Giuseppe Renne,C. De Cicco,F. De Lucia,R. Gennari +13 more
Journal ArticleDOI
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).
Raymond C. Rosen,Jens Altwein,Peter Boyle,Roger Kirby,Bertrand Lukacs,Eric J.H. Meuleman,Michael P. O'Leary,Paolo Puppo,Chris Robertson,François Giuliano +9 more
TL;DR: A large-scale, multinational survey was conducted in the US and six European countries to systematically investigate the relationship between lower urinary tract symptoms (LUTS) and sexual dysfunction in older men.
Journal ArticleDOI
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.
Journal ArticleDOI
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
James Lopez Bernal,James Lopez Bernal,James Lopez Bernal,Nick Andrews,Nick Andrews,Charlotte Gower,Chris Robertson,Julia Stowe,Elise Tessier,Ruth Simmons,Simon Cottrell,Richard J. Roberts,Mark G. O'Doherty,Kevin E. Brown,Claire Cameron,Diane Stockton,Jim McMenamin,Mary Ramsay,Mary Ramsay +18 more
TL;DR: In this paper, Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including the UK variant of concern B.1.7), admissions to hospital, and deaths.